Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IL-2 immunotherapy and HAART intensification in immunologic non-responder HIV patients
2006-003685-33Phase 3Completed
- Sponsor
- Luigi Sacco University Hospital
- Start
- Dec 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of aldesleukin in Human immunodeficiency virus infection type 1 and human immunodeficiency virus infection (HIV), sponsored by Luigi Sacco University Hospital. Started Dec 2006; status: completed.
02
Drugs
aldesleukin
03
Conditions
Human immunodeficiency virus infection type 1human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-003685-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003685-33.